Literature DB >> 3372028

Ciprofloxacin concentrations in tonsils following single or multiple administrations.

N Falser1, A Dalhoff, H Weuta.   

Abstract

Penetration of ciprofloxacin into human tonsils was studied in 20 adult humans undergoing tonsilectomy. Ten patients received a single intravenous infusion of 200 mg ciprofloxacin within 15 min (group A) and 14 patients were treated orally for three days with 500 mg ciprofloxacin b.i.d. prior to a preoperative infusion of 200 mg (group B). Ciprofloxacin concentrations in serum and tonsils were determined microbiologically. Mean ciprofloxacin serum concentrations did not differ significantly between both groups. Similarly, mean distribution ratios between tonsils and serum were not dissimilar, being on average 150% irrespective of whether the drug was administered once or repeatedly. Thus, a significant accumulation of ciprofloxacin was not observed either in the intravascular or in the extravascular space.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372028     DOI: 10.1007/bf01650501

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  27 in total

1.  Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administration.

Authors:  E Goormans; A Dalhoff; B Kazzaz; J Branolte
Journal:  Chemotherapy       Date:  1986       Impact factor: 2.544

2.  [Concentration of oxacillin, methicillin and veracillin in the blood serum and tonsils of patients with chronic tonsillitis].

Authors:  E V Ermol'eva; L A Gamaleia; T A Vasina; E A Ved'mina; G V Skurkovich
Journal:  Antibiotiki       Date:  1969-10

3.  Pharmacokinetics and tissue penetration of ciprofloxacin.

Authors:  B Crump; R Wise; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

4.  Dose- and sex-independent disposition of ciprofloxacin.

Authors:  D Höffler; A Dalhoff; W Gau; D Beermann; A Michl
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

5.  Single- and multiple-dose pharmacokinetics of pipemidic acid in normal human volunteers.

Authors:  E Klinge; P T Männistö; R Mäntylä; J Mattila; U Hänninen
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

6.  Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens.

Authors:  J A Hoogkamp-Korstanje; H J van Oort; J J Schipper; T van der Wal
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

7.  Multiple-dose ciprofloxacin kinetics in normal subjects.

Authors:  G E Aronoff; C H Kenner; R S Sloan; S T Pottratz
Journal:  Clin Pharmacol Ther       Date:  1984-09       Impact factor: 6.875

8.  Tissue distribution of ciprofloxacin following oral and intravenous administration.

Authors:  A Dalhoff; H U Eickenberg
Journal:  Infection       Date:  1985 Mar-Apr       Impact factor: 3.553

9.  Ciprofloxacin concentrations in tonsils following a single intravenous infusion.

Authors:  N Falser; A Dalhoff; H Weuta
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

10.  Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora.

Authors:  T Bergan; C Delin; S Johansen; I M Kolstad; C E Nord; S B Thorsteinsson
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

View more
  1 in total

Review 1.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.